XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Restatement of Previously Issued Financial Statements - Additional Information (Detail)
$ in Thousands
3 Months Ended
Sep. 30, 2021
USD ($)
Trails
Sep. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Targeted or Tracking Stock, Stock [Line Items]      
Number of clinical stage candidates | Trails 3    
Unrecognized tax benefits $ 0    
Revenue Recognised With Performance Obligation 7,800 $ 6,600  
Accumulated deficit (337,215) (277,679) $ (319,705)
Cash And Cash Equivalents,Short Term Investments And Common Stock Proceeds Receivable 145,500    
Increase in contract assets 538 2,061  
Contract with Customer, Liability, Revenue Recognized 417 (1,718)  
Revenue Recognized 99,600    
Increase (Decrease) in Deferred Revenue $ 20,417 $ (1,468)  
Pass through services      
Targeted or Tracking Stock, Stock [Line Items]      
Reimbursed cost 100.00%    
US License      
Targeted or Tracking Stock, Stock [Line Items]      
Revenue Recognized $ 64,500    
Ex US License      
Targeted or Tracking Stock, Stock [Line Items]      
Revenue Recognized $ 35,100